This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma in lead to acquire Zentiva for US 5.5 billion: ET ReportAurobindo Pharma arm gets marketing authorisation for Zefylti in EU
Alembic Pharma gets USFDA nod for Phytonadione Injectable Emulsion for hypoprothrombinemia due to vitamin K deficiencyAlembic Pharma gets USFDA EIR for Jarod facility
Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study WaivedZydus inks pact with Beihai Biotech for cancer drug Beizray commercialization in US
Granules recalls over 33000 bottles BP medication in USGlenmark, FDC Recall Hypertension, Glaucoma Drugs in US
USFDA Suspends Ixchiq Chikungunya Vaccine License Citing Encephalitis Death, 20+ Serious Adverse EventsSanofi's Merilog Receives USFDA Approval as Biosimilar to Novolog for Diabetes Management
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJohnson & Johnson Halts Late-Stage Trial of ExPEC9V Vaccine for Sepsis, Blood Infections
CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab TrialGSK's Meningococcal Vaccine Penmenvy Approved by USFDA
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag InternationalJohnson and Johnson Gets CDSCO Panel Nod To study Guselkumab in Psoriatic Arthritis
Aurobindo Pharma restarts production at Kakinada Penicillin-G plant after fire incidentAurobindo Pharma to Begin European Supply from China Facility in April
NPPA Panel Defers Biological Es Pneumonia Vaccine Price Exemption, Seeks ClarificationBiological E Gets CDSCO Panel Nod To Study Inactivated Poliomyelitis Vaccine
CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan ScientificHealth Ministry Invites Application For Deputy Director at CDSCO's CDTL Mumbai, Salary Up to Rs 2.09...
CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab TrialGSK Pharma's Q3 Profit Jumps 35% on Strong Demand for Augmentin, Respiratory Drugs
X